Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia.

Journal Article

OBJECTIVES: The genetic background of familial combined hyperlipidemia (FCHL) is currently unclear. We propose transcriptional profiling as a complementary tool for its understanding. Two hypotheses were tested: the existence of a disease-specific modification of gene expression in FCHL and the detectability of such a transcriptional profile in blood derived cell lines. METHODS AND RESULTS: We established lymphoblastic cell lines from FCHL patients and controls. The cells were cultured in fixed conditions and their basal expression profile was compared using microarrays; 166 genes were differentially expressed in FCHL-derived cell lines compared with controls, with enrichment in metabolism-related genes. Of note was the upregulation of EGR-1, previously found to be upregulated in the adipose tissue of FCHL patients, the upregulation of DCHR-7, the downregulation of LYPLA2, and the differential expression of several genes previously unrelated to FCHL. A cluster of potential EGR-1-regulated transcripts was also differentially expressed in FCHL cells. CONCLUSIONS: Our data indicate that in FCHL, a disease-specific transcription profile is detectable in immortalized cell lines easily obtained from peripheral blood and provide complementary information to classical genetic approaches to FCHL and/or the metabolic syndrome.

Full Text

Duke Authors

Cited Authors

  • Morello, F; de Bruin, TWA; Rotter, JI; Pratt, RE; van der Kallen, CJH; Hladik, GA; Dzau, VJ; Liew, C-C; Chen, Y-DI

Published Date

  • November 2004

Published In

Volume / Issue

  • 24 / 11

Start / End Page

  • 2149 - 2154

PubMed ID

  • 15388524

Electronic International Standard Serial Number (EISSN)

  • 1524-4636

Digital Object Identifier (DOI)

  • 10.1161/01.ATV.0000145978.70872.63

Language

  • eng

Conference Location

  • United States